Rapid RV/LV vs VX1+
AI Verdict
Choose Rapid RV/LV if…
Choose Rapid RV/LV if your primary need is a rapid, automated assessment of pulmonary embolism (PE) severity from CTPA scans. This tool is ideal for emergency departments or critical care settings where quick, objective measurements of right and left ventricle ratios are crucial for guiding immediate treatment decisions and patient triage for suspected PE cases.
View Rapid RV/LV →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist requiring real-time, AI-powered assistance during cardiac ablation procedures for atrial fibrillation or atrial tachycardia. This software is best suited for electrophysiology labs to help identify abnormal electrograms and optimize ablation targets during live procedures, integrating with existing EP recording and 3D mapping systems.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid RV/LV | VX1+ |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Unknown |
| Deployment | Unknown | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid RV/LVRapid RV/LV (Tool A) offers a fully automated software platform that provides rapid results within minutes of a scan, seamlessly integrating into existing PACS and radiology workflows without requiring manual intervention or altering normal procedures. VX1+ (Tool B), while featuring a simple user interface and real-time assistance, is used during complex, invasive electrophysiology procedures, necessitating more direct operator interaction with 3D mapping systems. Tool A's 'hands-off' automation and deep integration provide a superior user experience for its intended diagnostic context.
Clinical Value
VX1+Both tools are FDA-cleared and address critical clinical needs. Rapid RV/LV (Tool A) provides rapid, standardized assessment of pulmonary embolism severity, reducing inter-rater variability and time to diagnosis for a life-threatening condition. VX1+ (Tool B) offers real-time AI assistance during complex cardiac ablation procedures for atrial fibrillation, with clinical studies (Ev-AIFib, TAILORED-AF) demonstrating promising outcomes, including superior freedom from AF, and standardization of the procedure.
Pricing & Value
TieNeither Rapid RV/LV (Tool A) nor VX1+ (Tool B) provides publicly available pricing information, making a direct comparison of their financial value or cost-effectiveness impossible. Without transparent pricing or published economic analyses for either product, it is not possible to determine a winner in this dimension.
Enterprise Readiness
Rapid RV/LVRapid RV/LV (Tool A) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), alongside flexible deployment options (on-premises or hybrid) and integration with hospital LAN/firewall, PACS, RIS, and EHR systems. VX1+ (Tool B) integrates with existing EP recording and 3D mapping systems, but its HIPAA and BAA compliance are only 'expected' rather than explicitly stated in the provided information. Tool A's clear documentation of compliance and broader integration capabilities make it more robust for enterprise deployment.
Innovation
VX1+While Rapid RV/LV (Tool A) innovates by automating and standardizing a critical diagnostic measurement for PE, VX1+ (Tool B) demonstrates a higher degree of innovation by providing real-time, interactive AI guidance during a complex, invasive electrophysiology procedure. Its ability to annotate 3D anatomical maps and offer a 'Booster mode' for increased sensitivity, coupled with being the first FDA-cleared AI tool in interventional cardiac electrophysiology, highlights its pioneering application of AI in a live interventional workflow.
Support & Docs
Rapid RV/LVRapidAI (Tool A) offers comprehensive 24/7/365 customer support via email and phone across multiple countries, along with extensive online resources, guides, and learning materials. For Volta Medical (Tool B), while user manuals are mentioned, dedicated customer support specific to the VX1+ product, separate from other 'Volta' entities, is not clearly advertised or easily discoverable in the search results. Therefore, Tool A demonstrates a more robust and accessible support and documentation infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid RV/LV | VX1+ |
|---|---|---|
| Name | Rapid RV/LV | VX1+ |
| Company | RapidAI (formerly iSchemaView) | Volta Medical |
| Description | FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Surgical AI |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology |
| Key Features (Primary Focus) | AI-powered analysis of CTPA images, Automated measurement of right and left ventricle diameters, Calculation of RV/LV ratio | Real-time manual or automatic annotation of 3D anatomical and electrical maps, Identification of spatio-temporal dispersed electrograms (DEs) |
Videos
Demos, reviews, and walkthroughs featuring Rapid RV/LV and VX1+.